“At Pharmapack, we are presenting solutions that address two key trends in the pharma market,” explains Achim Schalk, Member of the Management Board of Gerresheimer AG. “The increasing share of biologics in new drug approvals and the trend toward home treatment with smart, digitally connected solutions for patient support.”
Preview: Gx InMonit – Smart add-on for autoinjectors
At the booth, in the Innovation Gallery and in a presentation on January 21, 2026, Gerresheimer will introduce Gx InMonit, a new, innovative add-on for autoinjectors such as the Gerresheimer Gx Inbeneo. The add-on is mounted on top of the autoinjector, guides patients through the administration process, and confirms successful injection via integrated screen and audio signals. The connected device transmits data to the cloud via cellular signal providing pharma companies with evidence of adherence. The Gx InMonit can be enhanced by connecting it to Gx AdheraLink which employs AI to interact with patients directly in a familiar messaging app. It reminds patients of injections, provides trustworthy information on their specific therapy, and gives positive reinforcement. This innovative integrated solution, consisting of an autoinjector, add-on, and AI-driven messaging, promotes confident self-management and adherence and can also provide health care providers with insights into therapy progress.
Conference highlight in the Learning Lab
At Pharmapack, Gerresheimer experts will give presentations on current industry topics:
Baked, Not Sprayed – Weighing the Pros and Cons of Baked-on Syringe Siliconization
Wednesday, January 21, 2026, 10:50 a.m. to 11:20 a.m. · 30 min.
Learning Lab – 4A89
Speaker: Christian Redeker, Global Product Manager Syringes
Gerresheimer's Inbeneo Autoinjector and AI-supported Connected Add-on: Improving the Patient Experience and Clinical Outcomes
Wednesday, January 21, 2026, 1:50 p.m. to 2:20 p.m. · 30 min.
Learning Lab – 4A89
Speaker: Giacomo Bruno, Digital Health Platform Lead
Optimizing Ethylene Oxide Sterilization: Sustainable Solutions for Pharmaceutical Packaging and Drug Delivery Devices
Thursday, January 22, 2026, 1:50 p.m. to 2:20 p.m. · 30 min.
Learning Lab – 4A89
Speaker: Bernd Zeiss, Head of Scientific Affairs and Application Technologies
Gerresheimer at Pharmapack in Paris
Gerresheimer will be presenting its product portfolio at Pharmapack in Paris, France, on January 21 and 22, 2026, in Hall 4, Booth #4G36.
Interested trade visitors can make an appointment with one of the Gerresheimer experts at Gerresheimer Pharmapack 2026.
About Gerresheimer
Gerresheimer is an innovative system and solution provider and global partner to the pharmaceutical, biotech, and cosmetics industries. The Group offers a comprehensive portfolio of drug containment solutions, including closures and accessories, as well as drug delivery systems, medical devices, and solutions for the healthcare industry. The range of services includes digital solutions for therapy support, on-body devices, syringes, pens, autoinjectors, and inhalers, as well as vials, cartridges, ampoules, tablet containers, infusion bottles, drip bottles, and syrup bottles. Gerresheimer ensures that drugs reach patients safely and can be administered reliably. Gerresheimer supports its customers with comprehensive services along the value chain and by addressing the growing demand for greater sustainability. With over 40 production sites in 16 countries in Europe, America, and Asia, Gerresheimer has a global presence and produces locally for regional markets. Together with Bormioli Pharma 2024, the Group generated sales of around EUR 2.4 billion and currently employs around 13,600 people. Gerresheimer AG is listed on the SDAX index of the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).
Contact Gerresheimer
